Sarshar Company has successfully completed the pilot production project for its immunochromatographic diagnostic kits and is now advancing products across three sectors: medical, veterinary, and food safety. The LABTELIGENCE brand has been designed with a focus on high performance, ease of use, and reliable accuracy, aiming to provide a comprehensive range of diagnostic tools for professionals in various fields.
In the area of veterinary infectious disease kits, FPV (Feline Panleukopenia Virus) and CPV (Canine Parvovirus) are recognized as two of the most common and concerning diseases among companion animals. The prevalence of these diseases—especially in young animals—has led veterinarians to seek rapid and accurate diagnostic solutions to prevent complications and limit potential disease spread. By offering immunochromatographic kits for infectious diseases in companion animals, Sarshar Company aims to improve the diagnostic process and facilitate clinical decision-making.
For the first time in Iran, the company has also introduced an antigen detection kit for Toxoplasma gondii. Previously, the domestic market was primarily focused on antibody-based detection; however, with LABTELIGENCE kits, it is now possible to perform detection using fecal samples as well. This innovation represents a significant step toward improving access to fast and accurate diagnostics, from small-scale farms to veterinary clinics.
Additionally, Sarshar Company has launched a Leishmania antibody detection kit, enabling veterinarians—particularly those with limited access to laboratory facilities—to achieve more reliable and accurate diagnoses. This suite of diagnostic kits is designed with a focus on simplifying the diagnostic process, ultimately aiming to enhance the quality of veterinary services and improve animal health.
For detailed technical specifications, usage instructions, pricing, and access to these kits, interested professionals can contact the company’s support unit or visit:
www.labtelligenc.com
